Leucid Bio
Pre-clinicalCAR T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers.
Founded
2017
Focus
Cell & Gene Therapy
About
CAR T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers.
Funding History
2Total raised: $30M
Series A$25MSynconaJun 15, 2021
Seed$5MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2017
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile